You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Hello and thank you for your great tool! It works great on my samples. I have a question regarding one of my samples, which is ultra-pure tumor (> 90% based on ASCAT) and a chromosome 6 loss.
First of all, I did a benchmarking on HLA types against Optitype. The normal sample types were complete match between SpecHLA and Optitype. For the tumor sample:
SpecHLA called HLAA01:23, Optitype called HLAA01:01
SpecHLA called HLAB44:05, Optitype called HLAB08:01
SpecHLA called HLAC05:01, Optitype called HLAC07:01
The discrepancy, I think, is because of the chromosome loss. Here is the results of LOH call:
I was expecting to see all HLAs being called LOH, due to the chromosome 6 loss.
My question to you is that whether you have tried SpecHLA on a highly pure tumor with CNVs on chr6? And I would like to get your opinion on these results and some guidance on how to improve it. Is there some parameters that need to be adjusted depending on the sample set?
Thank you,
Arash
The text was updated successfully, but these errors were encountered:
To improve it, you could use a higher value of the MAF by -r The minimum Minor Allele Frequency (MAF), default is 0.05 for full length and 0.1 for exon typing.
Hello and thank you for your great tool! It works great on my samples. I have a question regarding one of my samples, which is ultra-pure tumor (> 90% based on ASCAT) and a chromosome 6 loss.
First of all, I did a benchmarking on HLA types against Optitype. The normal sample types were complete match between SpecHLA and Optitype. For the tumor sample:
SpecHLA called HLAA01:23, Optitype called HLAA01:01
SpecHLA called HLAB44:05, Optitype called HLAB08:01
SpecHLA called HLAC05:01, Optitype called HLAC07:01
The discrepancy, I think, is because of the chromosome loss. Here is the results of LOH call:
I was expecting to see all HLAs being called LOH, due to the chromosome 6 loss.
My question to you is that whether you have tried SpecHLA on a highly pure tumor with CNVs on chr6? And I would like to get your opinion on these results and some guidance on how to improve it. Is there some parameters that need to be adjusted depending on the sample set?
Thank you,
Arash
The text was updated successfully, but these errors were encountered: